Get started
MODERNA INCMODERNA INCMODERNA INC

MODERNA INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MRNA chart


Full chart

MRNA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.28 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−8.965 EUR
Net income (FY)
‪−3.44 B‬ EUR
Revenue (FY)
‪3.13 B‬ EUR
Shares float
‪341.66 M‬
Beta (1Y)
1.06

Employees


Employees (FY)
‪5.8 K‬
Change (1Y)
+200 +3.57%
Revenue / Employee (1Y)
‪538.95 K‬ EUR
Net income / Employee (1Y)
‪−593.08 K‬ EUR

About Moderna, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Stéphane Bancel
Website
modernatx.com
Headquarters
Cambridge
Founded
2010
FIGI
BBG011RJBSB9
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MRNA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where MRNA is featured.

See all sparks 


Check out other big names from the same industry as MRNA.

Frequently Asked Questions


The current price of MRNA is 24.410 EUR — it has increased by 1.01% in the past 24 hours. Watch MODERNA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange MODERNA INC stocks are traded under the ticker MRNA.
MRNA stock has risen by 11.56% compared to the previous week, the month change is a −17.16% fall, over the last year MODERNA INC has showed a −75.80% decrease.
We've gathered analysts' opinions on MODERNA INC future price: according to them, MRNA price has a max estimate of 186.19 EUR and a min estimate of 17.57 EUR. Watch MRNA chart and read a more detailed MODERNA INC stock forecast: see what analysts think of MODERNA INC and suggest that you do with its stocks.
MRNA reached its all-time high on Aug 10, 2021 with the price of 423.850 EUR, and its all-time low was 20.805 EUR and was reached on Apr 7, 2025. View more price dynamics on MRNA chart.
See other stocks reaching their highest and lowest prices.
MRNA stock is 1.94% volatile and has beta coefficient of 1.06. Track MODERNA INC stock price on the chart and check out the list of the most volatile stocks — is MODERNA INC there?
Today MODERNA INC has the market capitalization of ‪9.28 B‬, it has increased by 6.15% over the last week.
Yes, you can track MODERNA INC financials in yearly and quarterly reports right on TradingView.
MODERNA INC is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
MRNA earnings for the last quarter are −2.81 EUR per share, whereas the estimation was −2.59 EUR resulting in a −8.57% surprise. The estimated earnings for the next quarter are −2.88 EUR per share. See more details about MODERNA INC earnings.
MODERNA INC revenue for the last quarter amounts to ‪933.13 M‬ EUR, despite the estimated figure of ‪910.74 M‬ EUR. In the next quarter, revenue is expected to reach ‪98.15 M‬ EUR.
MRNA net income for the last quarter is ‪−1.08 B‬ EUR, while the quarter before that showed ‪11.68 M‬ EUR of net income which accounts for ‪−9.37 K‬% change. Track more MODERNA INC financial stats to get the full picture.
No, MRNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 30, 2025, the company has ‪5.8 K‬ employees. See our rating of the largest employees — is MODERNA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MODERNA INC EBITDA is ‪−3.63 B‬ EUR, and current EBITDA margin is −116.07%. See more stats in MODERNA INC financial statements.
Like other stocks, MRNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MODERNA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MODERNA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MODERNA INC stock shows the sell signal. See more of MODERNA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.